Global Nuclear Medicine/Radiopharmaceuticals Market For Oncology, Thyroid, Cardiology
Latest
industry research report on: Global Nuclear
Medicine/Radiopharmaceuticals Market | Industry Size, Share,
Research, Reviews, Analysis, Strategies, Demand, Growth,
Segmentation, Parameters, Forecasts
The Nuclear
Medicine/Radiopharmaceuticals Market
has been comprehensively detailed in the report with special focus on
a range of key elements such as market share, forecast and base
figures, CAGR, driving factors, growth restraints, and business
opportunities. Buyers of the report are expected to be informed about
significant improvements in the market and its future outlook. This
could help them to take intelligent decisions when operating in the
business. In terms of segmentation, the report has exclusively
segregated the market to identify growth opportunities in different
segments and caution players about those with dwindling growth.
In
respect of competition, the global Nuclear
Medicine/Radiopharmaceuticals Market has been elaborately studied
with several leading players profiled in one of the most thorough and
near-accurate manners. Each player operating in the Nuclear
Medicine/Radiopharmaceuticals Market industry could be analyzed with
the help of this report based on its competitors, future growth
plans, market share, and recent developments. This is anticipated to
help readers gain a decisive insight of the competitive landscape so
they could modify their current business strategies or formulate new
ones to strengthen their position in the market.
Get Sample Report Of Nuclear Medicine/Radiopharmaceuticals Market
@ https://www.marketresearchreports.biz/sample/sample/1338409
This report studies the global Nuclear Medicine/Radiopharmaceuticals
market, analyzes and researches the Nuclear
Medicine/Radiopharmaceuticals development status and forecast in
United States, EU, Japan, China, India and Southeast Asia. This
report focuses on the top players in global market, like
- Cardinal Health
- Mallinckrodt
- GE Healthcare
- Lantheus Medical Imaging
- Bayer
- Bracco Imaging
- Eczacibasi-Monrol Nuclear Products
- Nordion
- Advanced Accelerator Applications
- IBA Molecular Imaging
Market segment by Regions/Countries, this report covers
- United States
- EU
- Japan
- China
- India
- Southeast Asia
Have Any Query? Ask Our Expert @
https://www.marketresearchreports.biz/sample/enquiryBuy/1338409
Market segment by Type, Nuclear
Medicine/Radiopharmaceuticals can be split into
- Diagnostic (SPECT-Technetium, PET-F-18)
- Therapeutic (Beta Emitters-I-131, Alpha Emitters, Brachytherapy-Y-90)
Market segment by Application,
Nuclear Medicine/Radiopharmaceuticals can be split into
- Oncology
- Thyroid
- Cardiology
Table
of Contents
Global Nuclear
Medicine/Radiopharmaceuticals Market Size, Status and Forecast 2022
1 Industry Overview of Nuclear
Medicine/Radiopharmaceuticals
1.1 Nuclear
Medicine/Radiopharmaceuticals Market Overview
1.1.1 Nuclear
Medicine/Radiopharmaceuticals Product Scope
1.1.2 Market Status and Outlook
1.2 Global Nuclear
Medicine/Radiopharmaceuticals Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Nuclear
Medicine/Radiopharmaceuticals Market by Type
1.3.1 Diagnostic
(SPECT-Technetium, PET-F-18)
1.3.2 Therapeutic (Beta
Emitters-I-131, Alpha Emitters, Brachytherapy-Y-90)
1.4 Nuclear
Medicine/Radiopharmaceuticals Market by End Users/Application
1.4.1 Oncology
1.4.2 Thyroid
1.4.3 Cardiology
2 Global Nuclear
Medicine/Radiopharmaceuticals Competition Analysis by Players
2.1 Nuclear
Medicine/Radiopharmaceuticals Market Size (Value) by Players (2016
and 2017)
2.2 Competitive Status and
Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service
Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in
Future
3 Company (Top Players)
Profiles
3.1 Cardinal Health
3.1.1 Company Profile
3.1.2 Main Business/Business
Overview
3.1.3 Products, Services and
Solutions
3.1.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Mallinckrodt
3.2.1 Company Profile
3.2.2 Main Business/Business
Overview
3.2.3 Products, Services and
Solutions
3.2.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GE Healthcare
3.3.1 Company Profile
3.3.2 Main Business/Business
Overview
3.3.3 Products, Services and
Solutions
3.3.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Lantheus Medical Imaging
3.4.1 Company Profile
3.4.2 Main Business/Business
Overview
3.4.3 Products, Services and
Solutions
3.4.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Bayer
3.5.1 Company Profile
3.5.2 Main Business/Business
Overview
3.5.3 Products, Services and
Solutions
3.5.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Bracco Imaging
3.6.1 Company Profile
3.6.2 Main Business/Business
Overview
3.6.3 Products, Services and
Solutions
3.6.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Eczacibasi-Monrol Nuclear
Products
3.7.1 Company Profile
3.7.2 Main Business/Business
Overview
3.7.3 Products, Services and
Solutions
3.7.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Nordion
3.8.1 Company Profile
3.8.2 Main Business/Business
Overview
3.8.3 Products, Services and
Solutions
3.8.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Advanced Accelerator
Applications
3.9.1 Company Profile
3.9.2 Main Business/Business
Overview
3.9.3 Products, Services and
Solutions
3.9.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 IBA Molecular Imaging
3.10.1 Company Profile
3.10.2 Main Business/Business
Overview
3.10.3 Products, Services and
Solutions
3.10.4 Nuclear
Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.10.5 Recent Developments
4 Global Nuclear
Medicine/Radiopharmaceuticals Market Size by Type and Application
(2012-2017)
4.1 Global Nuclear
Medicine/Radiopharmaceuticals Market Size by Type (2012-2017)
4.2 Global Nuclear
Medicine/Radiopharmaceuticals Market Size by Application (2012-2017)
4.3 Potential Application of
Nuclear Medicine/Radiopharmaceuticals in Future
4.4 Top Consumer/End Users of
Nuclear Medicine/Radiopharmaceuticals
5 United States Nuclear
Medicine/Radiopharmaceuticals Development Status and Outlook
5.1 United States Nuclear
Medicine/Radiopharmaceuticals Market Size (2012-2017)
5.2 United States Nuclear
Medicine/Radiopharmaceuticals Market Size and Market Share by Players
(2016 and 2017)
6 EU Nuclear
Medicine/Radiopharmaceuticals Development Status and Outlook
6.1 EU Nuclear
Medicine/Radiopharmaceuticals Market Size (2012-2017)
6.2 EU Nuclear
Medicine/Radiopharmaceuticals Market Size and Market Share by Players
(2016 and 2017)
7 Japan Nuclear
Medicine/Radiopharmaceuticals Development Status and Outlook
7.1 Japan Nuclear
Medicine/Radiopharmaceuticals Market Size (2012-2017)
7.2 Japan Nuclear
Medicine/Radiopharmaceuticals Market Size and Market Share by Players
(2016 and 2017)
8 China Nuclear
Medicine/Radiopharmaceuticals Development Status and Outlook
8.1 China Nuclear
Medicine/Radiopharmaceuticals Market Size (2012-2017)
8.2 China Nuclear
Medicine/Radiopharmaceuticals Market Size and Market Share by Players
(2016 and 2017)
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment